HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This is a prospective, non-randomised, 48 week study of the effect of protease inhibitor (PI)
containing and non-PI containing antiretroviral regimens on the expression of adipocyte
specific genes, protein levels and cellular structure in HIV-infected individuals, naive to
therapy, who are starting therapy for the first time.
Phase:
Phase 4
Details
Lead Sponsor:
Kirby Institute
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI) St Vincent's Hospital, Sydney